Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated c-myc messenger RNA in multiple myeloma cell lines.

R Fourney1, M Palmer, A Ng

  • 1Department of Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada.

Disease Markers
|May 1, 1990
PubMed
Summary

Researchers found significantly elevated c-myc messenger RNA (mRNA) levels in human myeloma cell lines. This suggests the c-myc proto-oncogene plays a crucial role in the development of myeloma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healing of bilateral humeral intracondylar fissures following placement of locking 4.5 mm transcondylar screws.

The Journal of small animal practice·2025
Same author

Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intention.

Journal of tissue viability·2025
Same author

Evaluation of learning and exposure in the undergraduate interventional radiology curriculum (ELIXIR).

Clinical radiology·2023
Same author

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies.

Frontiers in pharmacology·2023
Same author

Cognition in older offenders in North Rhine-Westphalia: A comparison of prisoners and patients in forensic psychiatry hospitals.

International journal of law and psychiatry·2023
Same author

A proof of concept for a deep learning system that can aid embryologists in predicting blastocyst survival after thaw.

Scientific reports·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Multiple myeloma is a cancer of plasma cells.
  • Proto-oncogenes are critical in cell growth and differentiation.
  • Dysregulation of proto-oncogenes can contribute to cancer development.

Purpose of the Study:

  • To investigate the role of specific oncogenes in human myeloma cell lines.
  • To determine if gene amplification or rearrangement of common oncogenes is present.
  • To assess the expression levels of c-myc proto-oncogene in myeloma.

Main Methods:

  • Analysis of oncogene amplification and rearrangement using DNA probes in four human myeloma cell lines.
  • Quantification of c-myc messenger RNA (mRNA) levels.
  • Assessment of c-myc mRNA half-life.

Related Experiment Videos

Main Results:

  • No evidence of amplification or rearrangement for tested oncogenes (met, raf, abl, mos, erb B, Her-2-neu, fos, myb-7, fms, L-myc, sis, myb-1).
  • Consistent and significant elevation (up to 23-fold) of c-myc mRNA observed in all cell lines.
  • No identified restriction fragment length polymorphism or gene amplification to explain c-myc mRNA elevation.
  • c-myc mRNA half-life was determined to be approximately 25 minutes.

Conclusions:

  • The study indicates that increased c-myc mRNA levels, not gene amplification or rearrangement, are associated with human myeloma cell lines.
  • These findings provide further evidence supporting the involvement of the c-myc proto-oncogene in the pathogenesis of multiple myeloma.